Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 26
Filtrar
1.
Int Orthop ; 48(2): 419-426, 2024 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-37672119

RESUMEN

PURPOSE: Short stems for total hip arthroplasty are an alternative to traditional conventional long stems. Short stems are designed to facilitate minimal-invasive surgery, improve bone-stock preservation, and mimic a physiological load distribution. However, there is little evidence of the long-term outcome of short stems. This study aims to analyze the ten year survival rates and clinical outcome of one specific metaphyseal short hip stem implant. METHODS: We retrospectively analyzed the patient records of the patients who underwent a total hip arthroplasty with a monoblock partial collum sparing metaphyseal short hip stem prosthesis in 2008 and 2009 in our clinic. Patients were contacted, and clinical follow-up was recorded using the German version of the modified Harris Hip Score. Furthermore, complications, revision surgery, and post-operative radiographs were analyzed. RESULTS: Data from 339 primary implantations in 322 patients were retrieved. The mean follow-up was 10.6 years. Seven patients underwent a revision. The ten year survival rate with any revision surgery as the endpoint was 97.5%. The mean modified Harris Hip Score was 86 points (range 30 to 91 points). Five patients had an intraoperative fracture of the femur (1.6%). Two patients (0.6%) had a dislocation of the hip. The stem tip-to-cortex distance, measured in the anterior posterior view, was 2.6 mm (range 0 to 8.3 mm). CONCLUSION: The ten year survival rate of our used monoblock partial collum sparing metaphyseal short hip stem implant is comparable to traditional stems for total hip arthroplasty.


Asunto(s)
Artroplastia de Reemplazo de Cadera , Prótesis de Cadera , Humanos , Artroplastia de Reemplazo de Cadera/efectos adversos , Estudios Retrospectivos , Estudios de Seguimiento , Diseño de Prótesis , Prótesis de Cadera/efectos adversos , Reoperación , Resultado del Tratamiento , Falla de Prótesis
2.
Front Public Health ; 11: 1114868, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37404270

RESUMEN

Background: Historically Black Colleges and Universities and Minority Serving Institutions are uniquely positioned to implement community-campus research partnerships based on a history of service, the pursuit of community trustworthiness and student demographics often similar to surrounding marginalized communities. The Morehouse School of Medicine Prevention Research Center collaborates with members of Historically Black Colleges and Universities, Minority Serving Institutes, and community organizations on the Community Engaged Course and Action Network. This network is the first of its kind and aims to strengthen members' ability to implement Community-Based Participatory Research (CBPR) principles and partnerships. Projects address public health priorities including mental health among communities of color, zoonotic disease prevention, and urban food deserts. Materials and methods: To assess the effectiveness of the network, a Participatory Evaluation framework was implemented to conduct process evaluation which included review of partnership structures, operations, project implementation processes, and preliminary outcomes of the research collaborations. A focus group of Community Engagement Course and Action Network members (community and academic) was also conducted to identify benefits and challenges of the network with emphasis on key areas for improvement to further enhance the relationships between partners and to facilitate their subsequent community-campus research. Results: Network improvements were tied to themes strengthening community-academic partnerships including sharing and fellowship, coalition building and collaboration, and greater connections and awareness of community needs through their current community-academic partnerships. The need to conduct ongoing evaluation during and after implementation, for determining the early adoption of CBPR approaches was also identified. Conclusion: Evaluation of the network's processes, infrastructure, and operation provides early lessons learned to strengthen the network. Ongoing assessment is also essential for ensuring continuous quality improvement across partnerships such as determining CBPR fidelity, assessing partnership synergy, and dynamics, and for quality improvement of research protocol. The implications and potential for advancing implementation science through this and similar networks are great towards advancing leadership in modeling how foundations in community service can advance to CBPR partnership formation and ultimately, health equity approaches, that are local defined and assessed.


Asunto(s)
Equidad en Salud , Humanos , Investigación Participativa Basada en la Comunidad/métodos , Conducta Cooperativa , Grupos Minoritarios , Universidades
3.
Unfallchirurg ; 120(9): 753-760, 2017 Sep.
Artículo en Alemán | MEDLINE | ID: mdl-27435484

RESUMEN

BACKGROUND: Tension band wiring after patellar fractures is related to a high number of implant-related complications (22-53 %). Revision surgery is necessary in 10-55 % of patients mostly with unsatisfactory results. The patella plate is an alternative treatment with the advantages of locked plating. The purpose of this study was to evaluate the first clinical prospective results and complications of this new implant. MATERIALS AND METHODS: Between April 2013 and May 2015 all patients that were treated with locked plating for patella fractures were included in this prospective study. Patients were followed-up clinically after six weeks and six months. RESULTS: Included in this study were 17 patients, 6 women and 11 men, with a mean age of 58 years (19-87). The knee range of motion was 120° after 6 weeks and improved to 138° after 6 months, corresponding to 84 % and 97 % of the range of motion of the healthy opposite knee. The Tegner activity scale increased from 2,5 to 3,5 (initial value: 4), the Lysholm score increased from 78 to 92 points (initial value: 97) and the Kujala score increased from 72 to 88 points (initial value: 96). Two complications occurred: one patient had a reactive bursitis prepatellaris and one patient sustained a loss of reduction. CONCLUSION: Locked plating of patella fractures is a reliable alternative treatment with good functional outcomes and low complication rates.


Asunto(s)
Placas Óseas , Fijación Interna de Fracturas , Rótula/lesiones , Adulto , Anciano , Anciano de 80 o más Años , Tornillos Óseos , Femenino , Estudios de Seguimiento , Humanos , Articulación de la Rodilla/fisiopatología , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/etiología , Complicaciones Posoperatorias/fisiopatología , Estudios Prospectivos , Rango del Movimiento Articular/fisiología , Adulto Joven
4.
Klin Padiatr ; 228(3): 149-56, 2016 Apr.
Artículo en Alemán | MEDLINE | ID: mdl-27135273

RESUMEN

INTRODUCTION: Considering that parental well-being influences the healing process of a child significantly, the relevance of psychosocial care of parents with children with cancer is obvious. Since the parental distress has hardly been studied in Germany, this study examines the burdens of parents of children with cancer. In addition, it provides a diagnostic tool that is used to standardize and facilitate the whole patient management. METHODS: n=213 parents have participated in the survey scheduled from September 2013 to September 2014 in pediatric oncology centers. The examination of parental distress was based on five burdens (namely "depression", "anxiety", "somatization", "posttraumatic stress disorder (PTSD)" and "obsessive-compulsive"). Moreover, confirmatory factor analyzes were calculated which form the basis of the tools. RESULTS: 42% of parents show above-average depression scores (z>1), 56,7% above-average anxiety scores, 30,6% above-average obsessive-compulsive scores, 17,4% above-average PTSD scores and 25,9% above-average somatization scores. The confirmatory factor analyzes provide evidence for a dimensional factor model and a second-order factor model. DISCUSSION: The results show that parents of children with cancer in Germany represent a risk group in terms of developing their own mental health problems.


Asunto(s)
Ajuste Emocional , Trastornos Mentales/diagnóstico , Trastornos Mentales/psicología , Neoplasias/diagnóstico , Neoplasias/psicología , Padres/psicología , Estrés Psicológico/complicaciones , Estrés Psicológico/psicología , Adolescente , Adulto , Niño , Preescolar , Femenino , Alemania , Hospitales Universitarios , Humanos , Masculino , Persona de Mediana Edad , Modelos Psicológicos , Relaciones Padres-Hijo , Manejo de Atención al Paciente , Psicometría/estadística & datos numéricos , Factores de Riesgo , Estrés Psicológico/diagnóstico , Encuestas y Cuestionarios
5.
Orthopade ; 38(8): 667-80, 2009 Aug.
Artículo en Alemán | MEDLINE | ID: mdl-19657621

RESUMEN

Cementless revision hip arthroplasty is described as state of the art, especially in cases of advanced bone loss of the femur. A requirement for a good result from cement-free revision hip arthroplasty is classification of the bone defect and the presence of a mechanically stable anchorage in the area of the original implant or, in cases of bone defects, distal to the original area in stable diaphyseal bone. The possibility of the accumulation of autografts or allogeneic osseous grafts and the entire removal of the cement and debris has been postulated. The advantages of cementless revision hip arthroplasty include regeneration of the bone stock and the often available modularity of the revision hip system, which allows adaptation to different bone configurations and also allows a partial change of the prosthesis in rerevision cases, such as in cases of sintering or derotation. Cemented revision arthroplasty should be done only in special cases, such as with marginal bone defects or for older patients with a short life expectancy.


Asunto(s)
Artroplastia de Reemplazo de Cadera/instrumentación , Fémur/cirugía , Prótesis de Cadera/clasificación , Inestabilidad de la Articulación/cirugía , Falla de Prótesis , Humanos , Selección de Paciente , Reoperación/instrumentación , Reoperación/métodos
6.
Parasite Immunol ; 30(10): 544-53, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18665903

RESUMEN

Previous studies have shown that IFN-gamma is essential for the pathogenesis of cerebral malaria (CM) induced by Plasmodium berghei ANKA (PbA) in mice. However, the exact role of IFN-gamma in the pathway (s) leading to CM has not yet been described. Here, we used 129P2Sv/ev mice which develop CM between 7 and 14 days post-infection with PbA. In this strain, both CD4(+) and CD8(+) T cells were involved in the effector phase of CM. When 129P2Sv/ev mice deficient in the IFN-gamma receptor alpha chain (IFN-gammaR1) were infected with PbA, CM did not occur. Migration of leucocytes to the brain at the time of CM was observed in wild type (WT) but not in deficient mice. However, in the latter, there was an accumulation of T cells in the lungs. Analysis of chemokines and their receptors in WT and in deficient mice revealed a complex, organ-specific pattern of expression. Up-regulation of RANTES/CCL5, IP-10/CCL3 and CCR2 was associated with leucocyte migration to the brain and increased expression of MCP-1/CCL2, IP-10/CCL3 and CCR5 with leucocyte migration to the lung. This shows that IFN-gamma controls trafficking of pathogenic T cells in the brain, thus providing an explanation for the organ-specific pathology induced by PbA infection.


Asunto(s)
Encéfalo/parasitología , Linfocitos T CD8-positivos/inmunología , Movimiento Celular , Malaria Cerebral/inmunología , Plasmodium berghei/inmunología , Animales , Encéfalo/inmunología , Linfocitos T CD8-positivos/parasitología , Quimiocinas/inmunología , Expresión Génica , Interferón gamma/inmunología , Pulmón/inmunología , Pulmón/parasitología , Malaria Cerebral/genética , Ratones , Neutrófilos/inmunología , Neutrófilos/parasitología , ARN/genética , Receptores de Quimiocina/inmunología , Receptores de Interferón/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Bazo/inmunología , Bazo/parasitología , Receptor de Interferón gamma
7.
Schmerz ; 22(1): 24-33, 2008 Feb.
Artículo en Alemán | MEDLINE | ID: mdl-18080145

RESUMEN

A complex electronic patient record was implemented in an interdisciplinary pain clinic. The goal was to create a tool that would allow structured access to the entries made by all specialty groups and permit data analysis for statistical and scientific purposes by means of integrated, coded fields. An electronic workflow was developed to facilitate the processing of documents. All entries dictated were converted to digital form and recorded directly into the electronic chart. Additional features included a structured medication list and a connection to the hospital's pre-existing electronic records. The various elements to be included in the chart were determined by an interdisciplinary team and progressively implemented using a commercially available system as a basis. In conclusion, implementation of a complex electronic patient record provides a valuable instrument for quality control, interdisciplinary collaboration and improved efficiency in a large, multimodal pain clinic.


Asunto(s)
Sistemas de Registros Médicos Computarizados/organización & administración , Clínicas de Dolor/organización & administración , Documentación/métodos , Capacitación en Servicio/organización & administración , Anamnesis , Grupo de Atención al Paciente , Programas Informáticos , Suiza
8.
Curr Top Microbiol Immunol ; 297: 103-43, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16265904

RESUMEN

Malaria remains a major global health problem and cerebral malaria is one of the most serious complications of this disease. Recent years have seen important advances in our understanding of the pathogenesis of cerebral malaria. Extensive analysis of tissues and blood taken from patients with cerebral malaria has been complimented by the use of animal models to identify specific components of pathogenic pathways. In particular, an important role for CD8+ T cells has been uncovered, as well divergent roles for members of the tumor necrosis factor (TNF) family of molecules, including TNF and lymphotoxin alpha. It has become apparent that there maybe more than one pathogenic pathway leading to cerebral malaria. The last few years have also seen the testing of vaccines designed to target malaria molecules that stimulate inflammatory responses and thereby prevent the development of cerebral malaria. In this review, we will discuss the above advancements, as well as other important findings in research into the pathogenesis of cerebral malaria. As our understanding of pathogenic responses to Plasmodium parasites gathers momentum, the chance of a breakthrough in the development of treatments and vaccines to prevent death from cerebral malaria have become more realistic.


Asunto(s)
Modelos Animales de Enfermedad , Células Endoteliales/metabolismo , Malaria Cerebral/inmunología , Malaria Cerebral/patología , Animales , Susceptibilidad a Enfermedades , Humanos , Leucocitos/inmunología , Malaria Cerebral/sangre , Malaria Cerebral/parasitología , Subgrupos de Linfocitos T/inmunología
9.
Unfallchirurg ; 107(1): 35-49, 2004 Jan.
Artículo en Alemán | MEDLINE | ID: mdl-14997874

RESUMEN

The incidence of periprosthetic fractures is increasing because of the increasing age and the rising number of joint replacements. Elderly patients are endangered because of a higher rate of co-morbidity such as osteoporosis or cardiovascular diseases. The treatment of periprosthetic fractures depends on these preconditions and has to solve the problem after an exact analysis of the fracture. An understanding of the biomechanical principles and risk factors is necessary for an effective treatment. Intraoperative and postoperative periprosthetic fractures will be discussed with emphasis on classification and treatment. The aim has to be an early functional postoperative treatment with partial/full weight bearing in order to avoid postoperative complications. In discussing the scope of periprosthetic fractures, the site, incidence, treatment and outcome of periprosthetic fractures of the hip and knee will be outlined.


Asunto(s)
Fracturas del Fémur , Fracturas Óseas , Prótesis de Cadera , Prótesis de la Rodilla , Factores de Edad , Anciano , Anciano de 80 o más Años , Artroplastia de Reemplazo de Cadera , Artroplastia de Reemplazo de Rodilla , Fenómenos Biomecánicos , Placas Óseas , Tornillos Óseos , Enfermedades Cardiovasculares/complicaciones , Fijadores Externos , Femenino , Fracturas del Fémur/diagnóstico por imagen , Fracturas del Fémur/cirugía , Fracturas Óseas/clasificación , Fracturas Óseas/diagnóstico por imagen , Fracturas Óseas/cirugía , Fracturas Óseas/terapia , Humanos , Masculino , Metaanálisis como Asunto , Osteoporosis/complicaciones , Cuidados Posoperatorios , Complicaciones Posoperatorias/prevención & control , Radiografía , Factores de Riesgo , Factores de Tiempo
10.
J Infect Dis ; 184(7): 892-7, 2001 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-11528591

RESUMEN

Screening of a Plasmodium falciparum genomic expression library for antigens expressed at the pre-erythrocytic stages resulted in the isolation of a recombinant phage (DG249) whose insert corresponded to regions II and III of a 175-kDa erythrocyte-binding antigen (EBA-175). EBA-175 is a parasite ligand implicated in red blood cell invasion. Reverse-transcriptase polymerase chain reaction, indirect immunofluorescent antibody test, and Western blot analysis confirmed that EBA-175 is expressed not only in blood-stage parasites but also in infected hepatocytes and on the sporozoite surface. The presence of EBA-175 on pre-erythrocytic parasites enhances the vaccine potential of this antigen by adding another target to the immune responses elicited by immunization.


Asunto(s)
Antígenos de Protozoos/genética , Proteínas Portadoras/genética , Hígado/parasitología , Plasmodium falciparum/inmunología , Proteínas Protozoarias/genética , Animales , Anticuerpos Antiprotozoarios/sangre , Anticuerpos Antiprotozoarios/inmunología , Antígenos de Protozoos/aislamiento & purificación , Western Blotting , Proteínas Portadoras/aislamiento & purificación , Técnica del Anticuerpo Fluorescente Indirecta , Biblioteca Genómica , Humanos , Malaria Falciparum/sangre , Malaria Falciparum/parasitología , Pan troglodytes/parasitología , Plasmodium falciparum/crecimiento & desarrollo , Proteínas Protozoarias/aislamiento & purificación , ARN Mensajero/análisis , ARN Protozoario/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
11.
Mol Biochem Parasitol ; 112(2): 253-61, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11223132

RESUMEN

The expression of the pfemp3 gene and the corresponding PfEMP3 knob-associated protein in the pre-erythrocytic stages of Plasmodium falciparum was demonstrated by RT-PCR, Western blots, IFAT and IEM. The antigen was found on the surface of the sporozoite and in the cytoplasm of mature hepatic stage parasites. Immunological cross-reactivity was observed with sporozoites from the rodent malaria parasites Plasmodium yoelii yoelii and Plasmodium berghei and was exploited to assess a potential role of this protein at the pre-erythrocytic stages. Specific antibodies from immune individuals were found to inhibit P. yoelii yoelii and P. berghei sporozoite invasion of primary hepatocyte cultures. PfEMP3 should now be added to the small list of proteins expressed at the pre-erythrocytic stages of P. falciparum, and its vaccine potential now deserves to be investigated.


Asunto(s)
Antígenos de Protozoos/inmunología , Antígenos de Protozoos/metabolismo , Proteínas de la Membrana/inmunología , Proteínas de la Membrana/metabolismo , Plasmodium falciparum/crecimiento & desarrollo , Plasmodium falciparum/inmunología , Animales , Anticuerpos Antiprotozoarios/inmunología , Antígenos de Protozoos/genética , Antígenos de Protozoos/ultraestructura , Western Blotting , Clonación Molecular , Secuencia Conservada , Reacciones Cruzadas/inmunología , Epítopos/inmunología , Eritrocitos/parasitología , Técnica del Anticuerpo Fluorescente Indirecta , Regulación del Desarrollo de la Expresión Génica , Hepatocitos/parasitología , Humanos , Sueros Inmunes/inmunología , Malaria/inmunología , Malaria/parasitología , Proteínas de la Membrana/genética , Proteínas de la Membrana/ultraestructura , Microscopía Inmunoelectrónica , Plasmodium/inmunología , Plasmodium falciparum/genética , Plasmodium falciparum/metabolismo , Proteínas Protozoarias , ARN Protozoario/genética , ARN Protozoario/metabolismo , Proteínas Recombinantes
14.
Biochemistry ; 38(10): 2899-908, 1999 Mar 09.
Artículo en Inglés | MEDLINE | ID: mdl-10074342

RESUMEN

Dihydroorotate dehydrogenase catalyzes the oxidation of dihydroorotate to orotate. The enzyme from Escherichia coli was overproduced and characterized in comparison with the dimeric Lactococcus lactis A enzyme, whose structure is known. The two enzymes represent two distinct evolutionary families of dihydroorotate dehydrogenases, but sedimentation in sucrose gradients suggests a dimeric structure also of the E. coli enzyme. Product inhibition showed that the E. coli enzyme, in contrast to the L. lactis enzyme, has separate binding sites for dihydroorotate and the electron acceptor. Trypsin readily cleaved the E. coli enzyme into two fragments of 182 and 154 residues, respectively. Cleavage reduced the activity more than 100-fold but left other molecular properties, including the heat stability, intact. The trypsin cleavage site, at R182, is positioned in a conserved region that, in the L. lactis enzyme, forms a loop where a cysteine residue is very critical for activity. In the corresponding position, the enzyme from E. coli has a serine residue. Mutagenesis of this residue (S175) to alanine or cysteine reduced the activities 10000- and 500-fold, respectively. The S175C mutant was also defective with respect to substrate and product binding. Structural and mechanistic differences between the two different families of dihydroorotate dehydrogenase are discussed.


Asunto(s)
Secuencia Conservada , Escherichia coli/enzimología , Mutagénesis Sitio-Dirigida , Oxidorreductasas actuantes sobre Donantes de Grupo CH-CH , Oxidorreductasas/metabolismo , Homología de Secuencia de Aminoácido , Tripsina/metabolismo , Sitios de Unión , Cromatografía en Gel , Dihidroorotato Deshidrogenasa , Activación Enzimática/genética , Estabilidad de Enzimas/genética , Hidrólisis , Isoenzimas/genética , Isoenzimas/metabolismo , Cinética , Oxidorreductasas/genética , Oxidorreductasas/aislamiento & purificación , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/aislamiento & purificación , Proteínas Recombinantes/metabolismo , Serina/genética , Espectrometría de Fluorescencia
15.
Strahlenther Onkol ; 175(12): 591-6, 1999 Dec.
Artículo en Alemán | MEDLINE | ID: mdl-10633784

RESUMEN

BACKGROUND: Between 1979 and 1997, a total of 92 patients with primary nasopharyngeal carcinoma were treated at the Hospitals of the University of Erlangen. Until 1988, radiotherapy alone was the treatment of choice and simultaneous radiochemotherapy was consistently applied thereafter. This retrospective analysis was performed to evaluate the influence of concurrent radiochemotherapy on survival and to identify possible prognostic factors on cause-specific survival-, locoregional tumor control- and distant-metastases-free survival rates. PATIENTS AND METHODS: Fifty-three patients (58%) received treatment by radiotherapy alone and 39 (42%) underwent primary radiochemotherapy with 2 courses of 5-FU and cisplatin. Median total dose to the bilateral neck region was 60 Gy (range, 50 to 62 Gy), and 74 Gy (range, 56 to 88 Gy) to the primary tumor. Median follow-up of the surviving patients was 8 years. RESULTS: Following radiochemotherapy and radiotherapy alone, the 5-year-survival rates were 67% and 48%, respectively (p = 0.06). Female patients had a survival advantage as compared to male patients (5-year-survival rate 77% vs 44%, p = 0.01). Patients with and without cranial nerve palsy at presentation had survival rates of 0% and 61%, respectively, at 5 years (p = 0.01). Distant-metastases-free survival was influenced by the following factors: lymph-node involvement (NO: 82% vs N1 to N3: 68%, p = 0.04), gender (female: 88% vs male: 64%, p = 0.01), type of treatment (radiochemotherapy: 86% vs radiotherapy: 63%, p = 0.02) and cranial nerve involvement (76% without and 42% with involvement, p = 0.04). CONCLUSIONS: In primary nasopharyngeal carcinoma simultaneous radiochemotherapy can significantly reduce distant metastases and improve survival as compared to radiotherapy alone. Since late toxicity rates were similar in both treatment groups and the slightly increased acute side effects following radiochemotherapy were effectively compensated by standard supportive care, patients with advanced nasopharyngeal carcinoma may benefit from simultaneous radiochemotherapy.


Asunto(s)
Carcinoma de Células Escamosas/tratamiento farmacológico , Carcinoma de Células Escamosas/radioterapia , Neoplasias Nasofaríngeas/tratamiento farmacológico , Neoplasias Nasofaríngeas/radioterapia , Adolescente , Adulto , Anciano , Antimetabolitos Antineoplásicos/administración & dosificación , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Carcinoma de Células Escamosas/mortalidad , Cisplatino/administración & dosificación , Terapia Combinada , Femenino , Fluorouracilo/administración & dosificación , Humanos , Masculino , Persona de Mediana Edad , Neoplasias Nasofaríngeas/mortalidad , Metástasis de la Neoplasia , Pronóstico , Dosificación Radioterapéutica , Factores de Tiempo
16.
J Surg Res ; 62(2): 278-83, 1996 May.
Artículo en Inglés | MEDLINE | ID: mdl-8632652

RESUMEN

Animal studies have shown that 21-aminosteroids have beneficial effects on cell and organ functions in several acute models of traumatic, hemorrhagic, and septic shock. However, it is not known if the 21-aminosteroid U74389G has any beneficial effect on organ functions in a recently developed chronic sheep model of multiple organ dysfunction after trauma. Furthermore, it is not known whether this drug has any effect on in vivo leukocyte function in this animal model. To study this, anesthetized animals were subjected to hemorrhagic shock (2 hr at a mean arterial blood pressure of 50 mmHg) and femoral reaming at Day 0. The following 5 days, endotoxin (ET; 0.75 micrograms/kg BW) and zymosan-activated plasma (ZAP; 20 ml/animal) were given every 12 hr. During the third phase (Days 6-10), the animals were merely observed. This kind of model resulted in progressive organ dysfunction indicated by increased cardiac output, decreased systemic vascular resistance, an increase of plasma-sorbitoldehydrogenase, impaired bilirubin metabolism, and impaired renal and lung function in nontreated animals. Animals receiving U74389G (3 mg/kg BW) during resuscitation from hemorrhagic shock and each time before ET/ZAP administration showed less severe organ dysfunction. Furthermore, U74389G showed beneficial effects on lung function, although it had no effect on accumulation of leukocytes in the lung or on the chemiluminescence response of isolated leukocytes from bronchoalveolar lavage fluid. These results suggest that U74389G may be a useful therapeutic agent in the prevention of multiple organ dysfunction after hemorrhagic and traumatic shock.


Asunto(s)
Antioxidantes/uso terapéutico , Insuficiencia Multiorgánica/prevención & control , Pregnatrienos/uso terapéutico , Choque Hemorrágico/tratamiento farmacológico , Alanina Transaminasa/sangre , Animales , Aspartato Aminotransferasas/sangre , Bilirrubina/sangre , Líquido del Lavado Bronquioalveolar/citología , Gasto Cardíaco , Femenino , Riñón/fisiopatología , L-Iditol 2-Deshidrogenasa/sangre , Recuento de Leucocitos , Neutrófilos/fisiología , Oxígeno/sangre , Estallido Respiratorio/efectos de los fármacos , Ovinos , Resistencia Vascular
17.
Eur J Clin Chem Clin Biochem ; 34(3): 207-14, 1996 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-8721408

RESUMEN

Trauma-induced multiple organ failure in sheep was prevented by aprotinin therapy. Multiple organ failure was induced in 16 female merino sheep by initial haemorrhagic shock and intramedullary femoral nailing (day 0), and 12 hourly injections of 0.75 micrograms/kg Escherichia coli endotoxin +0.7 ml/kg zymosan-activated plasma (days 1-5). In addition, the aprotinin group (n = 6) received simultaneous injections of 5 mg/kg (35 695 KIU/kg) aprotinin, whereas ten animals did not receive aprotinin and served as the control group (n = 10). Organ functions were monitored for a total of 11 days by measuring haemodynamic, cardio-respiratory and biochemical quantities of blood, urine and epithelial lining fluid. During the subsequent eleven day period, aprotinin induced a significant (p < 0.05) reduction of the pathological changes (development of multiple organ failure) seen in the control group. Thus, aprotinin prevented an alteration of cardiac function (cardiac index for control/aprotinin groups at day 1: 6.5/6.2, and at day 10: 10.47/7.0 1/min x m2), an impairment of lung function (mean pulmonary arterial pressure at day 1: 2.26/1.86, and at day 10: 3.83/2.13 kPa; epithelial lining fluid/plasma ratio of albumin concentrations as a direct marker of lung capillary permeability damage at day 0: 0.18/0.16, and at day 10: 0.45/0.15), a deterioration of liver function (plasma sorbitol dehydrogenase at day 0: 7.9/7.6, and at day 10: 29.6/7.4 U/1), but not of renal function (creatinine clearance at day 1: 91.4/66.1, and at day 10: 53.1/59.2 ml/min). Urinary aprotinin excretion increased up to day 3, then decreased rapidly despite further aprotinin administration. As a non-specific marker of cell damage, plasma lactate dehydrogenase indicated an aprotinin-induced organ protection (day 0: 501/409, and at day 10: 719/329 U/1). The neutrophil count and the measured chemiluminescence of neutrophils from the blood and epithelial lining fluid showed that aprotinin reduced the in vivo neutrophil activation, the alveolar neutrophil invasion, the production of inflammatory mediators, and the production of reactive oxygen metabolites during the passage of the capillary-interstitial-alveolar space by neutrophils.


Asunto(s)
Aprotinina/uso terapéutico , Hemostáticos/uso terapéutico , Insuficiencia Multiorgánica/prevención & control , Inhibidores de Serina Proteinasa/uso terapéutico , Heridas y Lesiones/complicaciones , Animales , Aprotinina/sangre , Aprotinina/orina , Permeabilidad Capilar/efectos de los fármacos , Modelos Animales de Enfermedad , Endotoxinas/administración & dosificación , Endotoxinas/toxicidad , Escherichia coli/metabolismo , Femenino , Arteria Femoral/efectos de los fármacos , Arteria Femoral/lesiones , Corazón/efectos de los fármacos , Corazón/fisiología , Hemodinámica/efectos de los fármacos , Hemorragia/inducido químicamente , Hemostáticos/administración & dosificación , Riñón/fisiología , L-Lactato Deshidrogenasa/sangre , Recuento de Leucocitos/efectos de los fármacos , Hígado/fisiología , Pulmón/fisiología , Insuficiencia Multiorgánica/etiología , Neutrófilos/efectos de los fármacos , Neutrófilos/fisiología , Inhibidores de Serina Proteinasa/sangre , Inhibidores de Serina Proteinasa/orina , Ovinos , Zimosan/química
19.
Clin Pharmacol Ther ; 39(3): 313-7, 1986 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-3948470

RESUMEN

Triamcinolone acetonide, triamcinolone hexacetonide, and a combination of betamethasone phosphate and acetate were given intra-articularly in different doses. Plasma levels of the steroids were measured and pharmacokinetic parameters were calculated. As a pharmacodynamic parameter for systemic steroid activity, plasma hydrocortisone levels were monitored for 3 weeks. Results indicate complete absorption from the site of injection over a period of 2 to 3 weeks. Because of its lower solubility, triamcinolone hexacetonide is absorbed slower than triamcinolone acetonide, thus maintaining synovial levels for a longer time and creating lower systemic corticoid levels. Endogenous hydrocortisone suppression correlated with exogenous steroid levels. Threshold concentrations for maximum suppression were determined.


Asunto(s)
Triamcinolona Acetonida/metabolismo , Absorción , Adolescente , Adulto , Anciano , Betametasona/sangre , Femenino , Semivida , Humanos , Hidrocortisona/sangre , Inyecciones Intraarticulares , Cinética , Masculino , Persona de Mediana Edad , Radioinmunoensayo , Triamcinolona Acetonida/análogos & derivados , Triamcinolona Acetonida/sangre
20.
Eur J Clin Pharmacol ; 31(3): 363-5, 1986.
Artículo en Inglés | MEDLINE | ID: mdl-3792436

RESUMEN

Seventy-five mg diclofenac sodium were given intramuscularly to 15 subjects alone and in combination with 40 mg triamcinolone acetate. Plasma levels of diclofenac were measured and pharmacokinetic parameters were calculated. The results indicate no statistically significant differences for most of the parameters. The maximum plasma concentrations (Cpmax) was increased by about 20% in combination with the glucocorticoid, whereas terminal elimination rate did not change significantly.


Asunto(s)
Diclofenaco/metabolismo , Triamcinolona/análogos & derivados , Adulto , Diclofenaco/administración & dosificación , Combinación de Medicamentos , Interacciones Farmacológicas , Humanos , Inyecciones Intramusculares , Cinética , Triamcinolona/administración & dosificación , Triamcinolona/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA